4th Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for BROWN'S COMPOUNDING

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies

LobbyistCovered position, as disclosed
TATE HOEFFEL —
WILL LE Com on House Administration & Depart. of Comm
JON W PLEBANI —
MICHAEL P STRAZZELLA —
JAMES C WILTRAUT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies

LobbyistCovered position, as disclosed
TATE HOEFFEL —
WILL LE Com on House Administration & Depart. of Comm
JON W PLEBANI —
MICHAEL P STRAZZELLA —
JAMES C WILTRAUT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies

LobbyistCovered position, as disclosed
TATE HOEFFEL —
WILL LE Com on House Administration & Depart of Comm
JON W PLEBANI —
MICHAEL P STRAZZELLA —
JAMES C WILTRAUT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Insurance INS

Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies

LobbyistCovered position, as disclosed
TATE HOEFFEL —
WILL LE Com on House Administration & Depart. of Comm
JON W PLEBANI —
MICHAEL P STRAZZELLA —
JAMES C WILTRAUT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.